- Research works
- 93 ▼ 43% vs 2013–17
- Citations
- 5k 53.8 per fractional work
- Top-10% rate
- 22.0% record average 16.5%
- Open access
- 46% world 28%
Not ranked overall: Eli Lilly (Singapore) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.4×. Every wedge is a field page.
- Immunology and Microbiology 4.4×
- Pharmacology, Toxicology and Pharmaceutics 3.5×
- Medicine 3.0×
- Mathematics 2.5×
- Biochemistry, Genetics and Molecular Biology 1.9×
- Chemistry 1.6×
- Neuroscience 1.4×
- Veterinary 1.3×
- Computer Science 1.1×
- Decision Sciences 0.8×
- Health Professions 0.7×
- Materials Science 0.6×
- Environmental Science 0.3×
- Engineering 0.2×
- Economics, Econometrics and Finance 0.2×
- Social Sciences 0.0×
Which keywords describe research at Eli Lilly (Singapore)?
By fractional works in all years, weighted toward what it does more of than the world: Glycemic Control, Insulin Therapy, Oxidative Stress, Clinical Guidelines, Diabetes, Biomarkers, Heart Failure and Depression.
- Mild Cognitive Impairment
- Tau Pathology
- Cognitive Function
- Therapeutic Strategies
- Medicinal Chemistry
- Synaptic Plasticity
- Hypoglycemia
- Cognitive Impairment
- Clinical Trials
- Type 1 Diabetes
- Neurodegeneration
- Alzheimer's Disease
- Genetics
- Type 2 Diabetes
- Cancer
- Diabetes
- Depression
- Clinical Guidelines
- Epidemiology
- Glycemic Control
- Oxidative Stress
- Insulin Therapy
- Cardiovascular Disease
- Inflammation
- Biomarkers
- Heart Failure
- Metabolic Syndrome
- Cardiovascular Outcomes
- Glucose Control
- Complications
- Neuroimaging
- Aging
- Diabetes Mellitus
- Continuous Glucose Monitoring
- Pharmacokinetics
- Neuroinflammation
- Primary Care
- Amyloid Hypothesis
- Neurodegenerative Diseases
- Dementia
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Oxidative Stress7▲ 4.3×18 topics
- Glycemic Control7▲ 56×4 topics
- Insulin Therapy7▲ 67×3 topics
- Epidemiology5▲ 1.38×36 topics
- Cardiovascular Disease5▲ 4.7×17 topics
- Clinical Guidelines5▲ 16×2 topics
- Inflammation5▲ 2.1×29 topics
- Depression4▲ 6.3×12 topics
- Biomarkers4▲ 7.3×8 topics
- Diabetes4▲ 8.8×8 topics
- Heart Failure4▲ 9.6×7 topics
- Cancer4▲ 2.8×23 topics
- Metabolic Syndrome4▲ 4.5×13 topics
- Type 2 Diabetes4▲ 21×2 topics
- Cardiovascular Outcomes3▲ 87×1 topic
- Genetics3▲ 4.8×8 topics
- Glucose Control3▲ 87×1 topic
- Alzheimer's Disease3▲ 12×6 topics
- Complications3▲ 6.5×4 topics
- Neurodegeneration3▲ 11×5 topics
- Neuroimaging3▲ 12×3 topics
- Type 1 Diabetes3▲ 33×2 topics
- Aging3▲ 5.7×4 topics
- Clinical Trials3▲ 4.7×11 topics
- Diabetes Mellitus3▲ 13×3 topics
- Cognitive Impairment3▲ 12×4 topics
- Continuous Glucose Monitoring3▲ 61×1 topic
- Hypoglycemia3▲ 61×1 topic
- Pharmacokinetics3▲ 10×3 topics
- Synaptic Plasticity3▲ 9.2×4 topics
- Neuroinflammation2▲ 9.7×3 topics
- Medicinal Chemistry2▲ 6.9×5 topics
- Primary Care2▲ 6.2×8 topics
- Therapeutic Strategies2▲ 27×2 topics
- Amyloid Hypothesis2▲ 43×1 topic
- Cognitive Function2▲ 11×5 topics
- Neurodegenerative Diseases2▲ 10×5 topics
- Tau Pathology2▲ 43×1 topic
- Dementia2▲ 31×1 topic
- Mild Cognitive Impairment2▲ 35×1 topic
Which research topics does Eli Lilly (Singapore) publish most on?
By volume in 2022–2025: Computational Drug Discovery Methods, Pancreatic function and diabetes, Inflammatory Bowel Disease and Alzheimer's disease research and treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Computational Drug Discovery Methods Computational Theory and Mathematics 1 works
- 2 Pancreatic function and diabetes Surgery 1 works
- 3 Inflammatory Bowel Disease Genetics 1 works
- 4 Alzheimer's disease research and treatments Physiology 1 works
- 5 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 1 works
- 6 Dementia and Cognitive Impairment Research Psychiatry and Mental health 0 works
- 7 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 0 works
- 8 Microscopic Colitis Epidemiology 0 works
- 9 Amyotrophic Lateral Sclerosis Research Neurology 0 works
- 10 Total Knee Arthroplasty Outcomes Surgery 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Eli Lilly (Singapore)'s research output changed?
Output in 2018–2022 was 43% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Singapore
- National University of Singapore
- Nanyang Technological University
- Agency for Science, Technology and Research
- Singapore General Hospital
- Singapore Management University
- National University Hospital
- Institute for Infocomm Research
- Singapore University of Technology and Design
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.